SOUP CANS LIMITED
Company number 14100909 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ORANJ LIMITED - Analysis Report
Company Number: 14100909
Analysis Date: 2025-07-29 13:55 UTC
Financial Health Score:
Grade: F (Dormant / Minimal Activity)
Explanation: ORANJ LIMITED is classified as a dormant company with minimal financial activity and essentially no operating assets or liabilities. This results in a financial health score at the lowest end of the spectrum, indicating an inactive business status rather than a traditionally "healthy" or "unhealthy" trading company.
Key Vital Signs
- Company Status: Active but dormant — no significant financial transactions during the reported financial years.
- Cash Balance: £1 across three consecutive years — effectively negligible cash presence, indicating no trading cash flow or operational liquidity.
- Net Assets & Shareholders' Funds: £1, corresponding to the nominal value of the single issued share — no retained earnings, no accumulated reserves.
- Account Category: Dormant — exemption from audit and minimal filing requirements.
- Director & Control: Single director and 100% owner, Mr. Jasper Delamothe, indicating centralized control with no other shareholders or management complexity.
- Industry Classification: Broad categories related to support services, head office activities, and holding company functions, but no operational activity reflected in financials.
Symptoms Analysis
The financial "vital signs" show symptoms typical of a company in stasis rather than distress:
- No Revenue or Expenses: The absence of trading data or operational turnover suggests the company has not commenced or has paused business activities.
- No Cash Generation or Burn: A static cash balance of £1 indicates no inflows or outflows, meaning the company is neither generating income nor incurring costs.
- No Financial Obligations: Without current liabilities or debts, there is no immediate financial stress or solvency risk, but also no growth or investment activity.
- Minimal Equity: The sole issued share at nominal value means no accumulated capital investment or reserves to support business expansion or absorb losses.
- Regulatory Compliance: Filing deadlines for accounts and confirmation statements are up to date, showing good governance despite dormancy.
Diagnosis
ORANJ LIMITED is clinically "dormant," akin to a patient in a medically induced coma or a hibernating organism. Its financial health is neither robust nor failing; rather, it is inactive. This status serves various strategic purposes such as preserving a company name, holding assets in a shell company, or preparing for future activation.
There are no signs of distress such as overdrafts, creditor pressure, or negative equity. However, the lack of operational data means the company currently generates no cash flow, profit, or business value. The absence of financial dynamics makes traditional health metrics (liquidity ratios, profitability, gearing) irrelevant at this stage.
Prognosis
If ORANJ LIMITED remains dormant, it will continue to show minimal financial activity and no growth. This is sustainable only if there are no external obligations requiring funding or trading operations. The prognosis is stable dormancy, not growth or decline.
Should the company wish to activate and trade, it will need capital infusion and operational planning to build healthy cash flow and operational assets. Without such action, the company will remain a "financial shell," which is neither a risk nor an opportunity until its status changes.
Recommendations
- Clarify Business Strategy: Define whether the company is intended to remain dormant as a holding or shell company, or if there are plans to commence trading.
- Maintain Compliance: Continue timely filing of dormant accounts and confirmation statements to preserve good standing and avoid penalties.
- Consider Capital Injection for Activation: If activating the business, plan for initial funding to build working capital and operational assets.
- Regular Review: Periodically reassess the company's status to ensure it aligns with strategic goals and regulatory requirements.
- Monitor Director Responsibilities: As sole director and controller, Mr. Delamothe should ensure full compliance with Companies House rules and consider potential liabilities if the company changes status.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.